in a randomized prospective study we tested the toxicity and efficacy of recombinant alpha-2 interferon in the treatment of kaposi 's sarcoma associated with the acquired immunodeficiency syndrome .
C0021734
alpha-2 interferon
C0001175
acquired immunodeficiency syndrome